COVID-19 vaccination in Canada
Older versions of this report are available on the archived reports page .
Doses administered
This page provides information on the number of COVID-19 vaccine doses that have been administered in Canada by jurisdiction, dose number and vaccine product. The number of vaccine doses administered is not the same as the number of people vaccinated.
We update information on the number of COVID-19 doses administered across Canada at different times:
- Key updates and updates from provincial and territorial websites are updated every weekday
- Reports from provinces and territories are updated every 4 weeks on Fridays at noon ET with data up to and including the previous Sunday.
On this page
- Key updates
- About COVID-19 vaccination and approved vaccines
- Updates from provincial and territorial websites New
- Reports from provinces and territories
- Suggested citation
Key updates as of {MMM DD, YYYY}
We update this number every weekday. Most provinces and territories do not update their numbers every day (see data sources ). Information is subject to change and may differ from provincial and territorial reports (see limitations ).
As most jurisdictions have reduced or stopped their regular update on doses administered on their website, we've removed the information on the number of doses administered the previous day.
About COVID-19 vaccination and approved vaccines
About COVID-19 vaccination and approved vaccines
Vaccination programs
- COVID-19 vaccination began in Canada on December 14, 2020.
- You’re currently eligible for COVID-19 vaccination if you’re 6 months of age or older and you don’t have contraindications to the vaccine.
-
The National Advisory Committee on Immunization (NACI) issues
statements with recommendations on the use of COVID-19 vaccines
. Briefly, NACI recommends:
- a complete primary vaccine series to provide protection against COVID-19
-
booster doses after completing the primary series to restore or improve protection against COVID-19. Please refer to the
COVID-19 vaccine chapter
of the
Canadian Immunization Guide
for more details on:
- booster eligibility
- timing of a booster dose
- recommended products
-
As part of the
fall 2022 COVID-19 booster program
, NACI recommends a COVID-19 vaccine booster 6 months after your last COVID-19 vaccine dose or SARS-CoV-2 infection.
- A booster dose should be offered to people at increased risk of severe illness from COVID-19, no matter how many booster doses they’ve already had.
- A booster may be offered to all others aged 12 to 64, no matter how many booster doses they’ve already had.
Approved vaccines
Vaccines authorized for use for primary vaccine series in Canada currently include:
2-dose vaccines
- Pfizer-BioNTech Comirnaty® (3 formulations: ages 6 months to under 5 years, ages 5 to 11 years, and ages 12 and older)
- Moderna Spikevax® (3 formulations: ages 6 months to 5 years, ages 6 to 11 years, and ages 12 and older)
- AstraZeneca Vaxzevria® (ages 18 and older)
- Novavax Nuvaxovid® (ages 18 and older)
- Medicago Covifenz® (ages 18 to 64)
1-dose vaccine
- Janssen Jcovden® (ages 18 and older)
Vaccines currently authorized for use as booster doses in Canada include:
- Pfizer-BioNTech Comirnaty® (Pfizer-BioNTech Comirnaty for ages 5 to 11 years and 16 and older, and Pfizer-BioNTech Comirnaty Bivalent for ages 12 and older)
- Moderna Spikevax® (Moderna Spikevax and Moderna Spikevax Bivalent COVID-19 vaccines, both for ages 18 and older)
Local information
For local information on doses administered, please see your province’s or territory’s COVID-19 vaccination website .
Doses administered: Updates from provincial and territorial websites Access and download the national COVID-19 vaccine administration data in .csv format
Altogether, {Total doses administered} vaccine doses have been administered as of {MMM DD, YYYY} .
Figure 1. Cumulative number of COVID-19 vaccine administered in Canada by jurisdiction, as of DD MMM YYYY HH PM
Hover over or select a portion of the map to see the cumulative number of COVID-19 vaccine doses administered in Canada and each jurisdiction over time.
Note: This information is based on the most current data available at the time of reporting. Green bars indicate the reported cumulative number of doses administered as of that date while grey bars are used for days where no data was reported. Due to differences in when provincial and territorial partners update their data, comparisons over time and between provinces and territories should be interpreted with caution (see data sources ). Information is subject to change and may differ from provincial and territorial reports depending on when data is updated (see limitations ).
Figure 1: Text description
Cumulative number of COVID-19 vaccine doses administered in Canada by jurisdiction as of MMM DD, YYYY
Doses administered: Reports from provinces and territories Access and download the national COVID-19 vaccine administration data by dose number and report week in .csv format
Information on doses administered by dose number and vaccine product is provided by provinces and territories every 4 weeks.
- In the last 4 weeks, the majority of doses administered were dose 4 or more.
Figure 2. Number of COVID-19 vaccine doses administered in every 4 weeks by dose number, as of MMM DD, YYYY
Hover over or select a bar to see the number of doses administered by dose number and report week.
Figure 2. Number of COVID-19 vaccine doses administered in Canada every 4 weeks by dose number and jurisdiction, {MMM DD, YYYY}
Figure 2: Text description
Table 1. Cumulative number of COVID-19 vaccine doses administered in by vaccine product and dose number, as of MMM DD, YYYY
Vaccine product | Total doses | Dose 1 | Dose 2 | Dose 3 | Dose 4 | Dose 5+ |
---|
Figure 3. Vaccine product breakdown of COVID-19 vaccine doses administered in by dose number, as of MMM DD, YYYY Access and download the national COVID-19 vaccine administration data by dose number and report week in .csv format
Hover over or select a bar to see the cumulative percentage of doses administered by dose number and vaccine product. Click on a legend element to add or remove the corresponding bars from the graph.
Figure 3. Vaccine product breakdown of COVID-19 vaccine doses administered in Canada by dose number, as of MMM DD, YYYY
Figure 3: Text description
Week ending | Jurisdiction | Vaccine product | Total doses | Dose 1 | Dose 2 | Dose 3 | Dose 4 | Dose 5+ |
---|
Suggested citation
Public Health Agency of Canada. Canadian report on COVID-19 vaccine doses administered. Ottawa: Public Health Agency of Canada; MMM DD, YYYY . https://health-infobase.canada.ca/covid-19/vaccine-administration/
Related links
- Vaccines for COVID-19
- Vaccine distribution
- Reported side effects following COVID-19 vaccination in Canada
- COVID-19 daily epidemiology update: Cases following vaccination
- COVID-19: Effectiveness and benefits of vaccination
- COVID-19 Vaccination Coverage Survey (CVCS)
- COVID-19 vaccine uptake and intent: Canadian Community Health Survey (CCHS) insight
- Canada's COVID-19 immunization plan
- The facts about COVID-19 vaccines
- Vaccines for children
- Ask the experts video series: COVID-19 vaccines questions
For health professionals
- COVID-19 information for health professionals
- National Advisory Committee on Immunization (NACI)
- COVID-19 daily epidemiology update
Provincial, territorial and other federal COVID-19 vaccination webpages
- British Columbia
- Alberta
- Saskatchewan
- Manitoba
- Ontario
- Quebec
- New Brunswick
- Nova Scotia
- Prince Edward Island
- Newfoundland and Labrador
- Yukon
- Northwest Territories
- Nunavut
- Indigenous Services Canada
- Correctional Service Canada
- Date modified: